Remgro Ltd (REM) Share Price & Latest SENS Announcements

REMGRO LIMITED - Notice of an acquisition of a beneficial interest in Remgro Limited securities

Ninety One crosses 5% beneficial-interest threshold at 5.0156% — a mandatory ownership disclosure, not an investment signal.

REMGRO LIMITED - Notice of an acquisition of a beneficial interest in Remgro Limited securities

Asset manager Ninety One discloses a 5.0004% holding — routine regulatory filing, no investment signal.

REMGRO LIMITED - Restructuring of interests in Mediclinic Holdings implementation of transaction

Mediclinic restructuring closed 1 July 2026 as announced; terms unchanged from March Category 2 disclosure.

REMGRO LIMITED - Summary of Mediclinic Holdings Limited results for the year ended 31 March 2026

Mediclinic reports a $733m loss on $1.24bn in impairments, despite strong adjusted operating growth.

REMGRO LIMITED - Completion of disposal of shares held in FirstRand Limited

Remgro completed its FirstRand exit, securing R3.59 billion to fund ongoing portfolio restructuring.

REMGRO LIMITED - Dealings in securities by an executive director

Executive director sells R1.24 million in shares following routine vesting of performance awards.

REMGRO LIMITED - Dealings in securities by executive directors, prescribed officers and the company secretary

Routine insider share sales to settle tax liabilities following the vesting of performance awards.

REMGRO LIMITED - Acceptance of awards by executive directors, prescribed officers and company secretary

Remgro executives have accepted routine performance and retention share awards under the long-term incentive plan.

REMGRO LIMITED - Restructuring of interests in Mediclinic Holdings and withdrawal of cautionary announcement

Remgro swaps its Swiss healthcare stake for full control of Southern African assets, withdrawing its cautionary.